Cargando…

(41) Screening for Brain Fog: Is the Montreal Cognitive Assessment an Effective Screening Tool for Neurocognitive complaints Post-COVID-19?

Detalles Bibliográficos
Autores principales:	Lynch, Sean T., Ferrando, Stephen J., Dornbush, Rhea L., Shahar, Sivan, Smiley, Abbas, Klepacz, Lidia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646375/ http://dx.doi.org/10.1016/j.jaclp.2022.10.044

Ejemplares similares

Screening for brain fog: Is the montreal cognitive assessment an effective screening tool for neurocognitive complaints post-COVID-19?
por: Lynch, Sean, et al.
Publicado: (2022)

Frequency and Characteristics of Depression and Its Association with Diminished Quality of Life in a Cohort of Individuals with Post-Acute Sequelae of COVID-19
por: Shahar, Sivan, et al.
Publicado: (2023)

Impact of COVID-19 on employment: sociodemographic, medical, psychiatric and neuropsychological correlates
por: Thompson, Madison, et al.
Publicado: (2023)

Anxiety and posttraumatic stress in post-acute sequelae of COVID-19: prevalence, characteristics, comorbidity, and clinical correlates
por: Ferrando, Stephen J., et al.
Publicado: (2023)

Psychiatric emergencies during the height of the COVID-19 pandemic in the suburban New York City area
por: Ferrando, Stephen J., et al.
Publicado: (2021)

Neuropsychological, Medical, and Psychiatric Findings After Recovery From Acute COVID-19: A Cross-sectional Study
por: Ferrando, Stephen J., et al.
Publicado: (2022)

Characteristics of Calls to a COVID-19 Mental Health Hotline in the First Wave of the Pandemic in New York
por: Abdullah, Hussain, et al.
Publicado: (2021)

Olfactory Hallucinations in the Context of Coronavirus Disease 2019
por: Kumar, Parul, et al.
Publicado: (2021)

Post-traumatic stress disorder can be predicted in hospitalized blunt trauma patients using a simple screening tool
por: Rahmat, Saad, et al.
Publicado: (2021)

COVID-19 Psychosis: A Potential New Neuropsychiatric Condition Triggered by Novel Coronavirus Infection and the Inflammatory Response?
por: Ferrando, Stephen J., et al.
Publicado: (2020)

Montreal Cognitive Assessment as Screening Measure for Mild and Major Neurocognitive Disorder in a Chilean Population
por: Bello-Lepe, Sebastian, et al.
Publicado: (2020)

Montreal Brain Injury Vision Screening Test for General Practitioners
por: Abbas Farishta, Reza, et al.
Publicado: (2022)

Validity and reliability of two alternate versions of the Montreal Cognitive Assessment (Hong Kong version) for screening of Mild Neurocognitive Disorder
por: Wong, Adrian, et al.
Publicado: (2018)

Montreal cognitive assessment in primary sjogren’s syndrome: A brief screening tool
por: Kurtuluş, Fatma, et al.
Publicado: (2019)

Evaluation of the Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in SLE
por: Raghunath, Sudha, et al.
Publicado: (2021)

Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex
por: Hugon, Jacques, et al.
Publicado: (2021)

Computerized screening tools for neurocognitive impairment in patients with HIV infection
por: Cercel, Ioana-Catrinel, et al.
Publicado: (2014)

Montreal Cognitive Assessment — Single Cutoff Achieves Screening Purpose
por: Yeung, Pui Yu, et al.
Publicado: (2020)

When Did the Empathy Die?: Examining the Correlation Between Length of Medical Training and Level of Empathy
por: Dinoff, Adam, et al.
Publicado: (2023)

Routine cognitive screening in older patients admitted to acute medicine: abbreviated mental test score (AMTS) and subjective memory complaint versus Montreal Cognitive Assessment and IQCODE
por: Pendlebury, S. T., et al.
Publicado: (2015)

The Montreal Cognitive Assessment Test: A Useful Tool in Screening of Cognitive Impairment in Patients With Systemic Lupus Erythematosus
por: Paez-Venegas, Nicolas, et al.
Publicado: (2019)

The Screening Accuracy of a Visually Based Montreal Cognitive Assessment Tool for Older Adult Hearing Aid Users
por: Utoomprurkporn, Nattawan, et al.
Publicado: (2021)

Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature
por: Zipursky, Amy R., et al.
Publicado: (2013)

Fog Computing
por: Abbas, Assad, et al.
Publicado: (2020)

Psychosocial profile of pediatric brain tumor survivors with neurocognitive complaints
por: de Ruiter, Marieke Anna, et al.
Publicado: (2015)

Phototest for neurocognitive screening in multiple sclerosis
por: Pinto, Joana, et al.
Publicado: (2016)

Brain fog in postural tachycardia syndrome: An objective cerebral blood flow and neurocognitive analysis
por: Wells, Rachel, et al.
Publicado: (2020)

The Montreal cognitive assessment as a cognitive screening tool in sickle cell disease: Associations with clinically significant cognitive domains
por: Early, Macy L., et al.
Publicado: (2022)

Effects of Demographic Variables on Subjective Neurocognitive Complaints Using the Neurocognitive Questionnaire (NCQ) in an Aged Japanese Population
por: Yamada, Michiko, et al.
Publicado: (2019)

Comparison of Rapid Cognitive Screen against Montreal Cognitive Assessment in screening for cognitive impairment in the old and old‐old
por: Chen, Matthew Zhixuan, et al.
Publicado: (2022)

Cognitive screening for adult psychiatric outpatients: Comparison of the Cognivue(®) to the Montreal Cognitive Assessment
por: Rose, Amanda F, et al.
Publicado: (2021)

A better screening tool for HIV-associated neurocognitive disorders: is it what clinicians need?
por: Brouillette, Marie-J., et al.
Publicado: (2015)

Risk factors for neurocognitive impairment in HIV-infected patients and comparison of different screening tools
por: de Souza, Elisa Moreira, et al.
Publicado: (2016)

Neurocognitive Screening in Patients Following SARS-CoV-2 Infection: Tools for Triage
por: Blackmon, Karen, et al.
Publicado: (2022)

Neurocognitive screening in patients following SARS-CoV-2 infection: tools for triage
por: Blackmon, Karen, et al.
Publicado: (2022)

The Beijing version of the montreal cognitive assessment as a brief screening tool for mild cognitive impairment: a community-based study
por: Yu, Jing, et al.
Publicado: (2012)

Using the Montreal Cognitive Assessment Scale to screen for dementia in Chinese patients with Parkinson's Disease
por: CHEN, Ling, et al.
Publicado: (2013)

Enhanced diagnostic accuracy for neurocognitive disorders: a revised cut-off approach for the Montreal Cognitive Assessment
por: Thomann, Alessandra E., et al.
Publicado: (2020)

Validation of the Argentine version of the Montreal Cognitive Assessment Test (MOCA): A screening tool for Mild Cognitive Impairment and Mild Dementia in Elderly
por: Serrano, Cecilia M., et al.
Publicado: (2020)

Montreal
por: Dell, Harry H.
Publicado: (1896)

Cannot write session to /tmp/vufind_sessions/sess_2kc84vj12qu5qal2c4ll0nkdhr